Amylyx Pharmaceuticals to remove ALS drug from US, Canada markets

Amylyx Pharmaceuticals

04/04/2024 12:07

April 4 (Reuters) - Amylyx Pharmaceuticals  AMLX.O  said
on Thursday it would withdraw its amyotrophic lateral sclerosis
(ALS) drug from the U.S. and Canada markets after the treatment
failed in a crucial late-stage trial.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi
Majumdar)
 ((Sriparna.Roy@thomsonreuters.com;))